Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Uharek

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|January 30, 2014
Genetically modified T cells for the treatment of malignant diseaseAgnieszka Wieczorek, Lutz Uharek
Biomarker Insights|February 27, 2016
Management of Chronic Myeloid Leukemia Patients Resistant to Tyrosine Kinase Inhibitors TreatmentAgnieszka Wieczorek, Lutz Uharek
British Journal of Haematology|August 16, 2005
Air embolism simulating atypical pneumoniaOlaf Penack, Karl-Jürgen Wolf, Lutz Uharek
Expert Opinion on Pharmacotherapy|December 2, 2004
Therapeutic spectrum in the treatment of myelodysplastic syndromesWolf-K Hofmann, Claudia Baldus, Lutz Uharek, et al.
British Journal of Haematology|March 29, 2002
Enhanced antitumoral effectiveness of idiotype vaccination induced by the administration of Flt3 ligand combined with interleukin 2 against a murine myelomaMatthias Zeis, Tim Zunkel, Jörg Steinmann, et al.
Cytotherapy|March 18, 2014
Immunotherapy: opportunities, risks and future perspectivesMartin Hildebrandt, Karl Peggs, Lutz Uharek, et al.
Leukemia & Lymphoma|November 26, 2008
Central nervous system infections in immunocompromised patients: update on diagnostics and therapyMartin Schmidt-Hieber, Janine Zweigner, Lutz Uharek, et al.
Annals of Hematology|August 31, 2014
Association between low uric acid levels and acute graft-versus-host diseaseBenjamin N Ostendorf, Olga Blau, Lutz Uharek, et al.
British Journal of Haematology|December 21, 2002
Therapeutic effects of idiotype vaccination can be enhanced by the combination of granulocyte-macrophage colony-stimulating factor and interleukin 2 in a myeloma modelJan Stritzke, Tim Zunkel, Jörg Steinmann, et al.
Best Practice & Research. Clinical Haematology|September 26, 2006
Natural-killer-cell-based treatment in haematopoietic stem-cell transplantationJakob R Passweg, Ulrike Koehl, Lutz Uharek, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|January 30, 2014
Genetically modified T cells for the treatment of malignant diseaseAgnieszka Wieczorek, Lutz Uharek
Biomarker Insights|February 27, 2016
Management of Chronic Myeloid Leukemia Patients Resistant to Tyrosine Kinase Inhibitors TreatmentAgnieszka Wieczorek, Lutz Uharek
British Journal of Haematology|August 16, 2005
Air embolism simulating atypical pneumoniaOlaf Penack, Karl-Jürgen Wolf, Lutz Uharek
Expert Opinion on Pharmacotherapy|December 2, 2004
Therapeutic spectrum in the treatment of myelodysplastic syndromesWolf-K Hofmann, Claudia Baldus, Lutz Uharek, et al.
British Journal of Haematology|March 29, 2002
Enhanced antitumoral effectiveness of idiotype vaccination induced by the administration of Flt3 ligand combined with interleukin 2 against a murine myelomaMatthias Zeis, Tim Zunkel, Jörg Steinmann, et al.
Cytotherapy|March 18, 2014
Immunotherapy: opportunities, risks and future perspectivesMartin Hildebrandt, Karl Peggs, Lutz Uharek, et al.
Leukemia & Lymphoma|November 26, 2008
Central nervous system infections in immunocompromised patients: update on diagnostics and therapyMartin Schmidt-Hieber, Janine Zweigner, Lutz Uharek, et al.
Annals of Hematology|August 31, 2014
Association between low uric acid levels and acute graft-versus-host diseaseBenjamin N Ostendorf, Olga Blau, Lutz Uharek, et al.
British Journal of Haematology|December 21, 2002
Therapeutic effects of idiotype vaccination can be enhanced by the combination of granulocyte-macrophage colony-stimulating factor and interleukin 2 in a myeloma modelJan Stritzke, Tim Zunkel, Jörg Steinmann, et al.
Best Practice & Research. Clinical Haematology|September 26, 2006
Natural-killer-cell-based treatment in haematopoietic stem-cell transplantationJakob R Passweg, Ulrike Koehl, Lutz Uharek, et al.
Pageof 5